EP2870246
Fákirni til meðferðar sjúklinga með vöðvarýrnun
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
3.7.2013EP published:
11.9.2019EP application number:
13739847.5
EP translation filed:
22.11.2019Grant published:
15.12.2019EPO information:
European Patent Register
Max expiry date:
2.7.2033Expiry date:
2.7.2025
Title:
OLIGONUCLEOTIDE FOR THE TREATMENT OF MUSCULAR DYSTROPHY PATIENTS
Timeline
Today
3.7.2013EP application
11.9.2019EP Publication
22.11.2019Translation submitted
15.12.2019Registration published
2.7.2025Expires
Owner
Name:
BioMarin Technologies B.V.Address:
J.H. Oortweg 21, 2333, CH Leiden, NL
Inventor
Name:
VAN DEUTEKOM, Judith Christina TheodoraAddress:
AA Dordrecht, NL
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
12174781Date:
3.7.2012Country:
EP
Number:
201261667517 PDate:
3.7.2012Country:
US
Classification
Categories:
C12N 15/113, A61K 31/7088
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 1.7.2020
Expires: 2.7.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 18.6.2021
Expires: 2.7.2022
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 21.6.2022
Expires: 2.7.2023
Payer: Patice ehf.
Number: 11
Paid: 22.6.2023
Expires: 2.7.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 19.6.2024
Expires: 2.7.2025
Payer: Árnason Faktor ehf.